SCHEMBL15977837

SCHEMBL15977837

c1ccc2c(c1)cc(-c1c3ccccc3c(-c3cc4ccccc4c4ccccc34)c3cc(-c4ccc(-c5ccncc5)cc4)ccc13)c1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.47
PIK3CA P42336 1/20 0.43
IMPDH2 P12268 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41
DHODH Q02127 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
NISCH Q9Y2I1 1/20 0.39
NOTUM Q6P988 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
CHEK1 O14757 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
ALK Q9UM73 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977839 0.94 CYP11B1 (0.47) CYP11B1PIK3CAIMPDH2MKNK1DHODH
SCHEMBL15977841 0.93 ALDH1A1 (0.44) CYP11B1PIK3CAIMPDH2MKNK1DHODH
SCHEMBL15977820 0.87 CYP11B1 (0.43) CYP11B1PIK3CAIMPDH2DHODHHSD17B1
SCHEMBL15977927 0.85 CYP11B1 (0.66) CYP11B1PIK3CADHODHHSD17B1HSD17B2
SCHEMBL15977863 0.85 PIK3CA (0.39) CYP11B1PIK3CAIMPDH2DHODHHSD17B1
SCHEMBL15977852 0.84 KDM4E (0.49) PIK3CAIMPDH2MKNK1DHODHHSD17B1
SCHEMBL15977613 0.83 CYP11B1 (0.42) CYP11B1PIK3CAIMPDH2MKNK1DHODH
SCHEMBL15977932 0.83 CYP11B1 (0.42) CYP11B1PIK3CAIMPDH2MKNK1DHODH
SCHEMBL22993071 0.83 GPR84 (0.46) CYP11B1HSD17B1HSD17B2KDM4EALDH1A1
SCHEMBL22993068 0.83 GPR84 (0.46) CYP11B1HSD17B1HSD17B2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP11B1 1241/4885PIK3CA 2722/4885IMPDH2 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.